Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Filgotinib in the Treatment of Perianal Fistulizing Crohn's Disease [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating filgotinib for fistulizing Crohn's disease has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Fistulizing Crohn Disease

Drugs mentioned

• Filgotinib (filgotinib)

Snippet

Sponsor: Gilead Sciences | Conditions: Fistulizing Crohn's Disease | Phase 2 | Status: COMPLETED | Results posted: 2022-04-08